Literature DB >> 18267111

Dehydroabietic acid, a phytochemical, acts as ligand for PPARs in macrophages and adipocytes to regulate inflammation.

Min-Sook Kang1, Shizuka Hirai, Tsuyoshi Goto, Kayo Kuroyanagi, Joo-Young Lee, Taku Uemura, Yoichiro Ezaki, Nobuyuki Takahashi, Teruo Kawada.   

Abstract

Obesity is characterized by an enhanced infiltration of macrophages to adipose tissues, which is closely associated with the low-grade inflammatory state and obesity-related pathologies such as type 2 diabetes and cardiovascular diseases. We showed here that dehydroabietic acid (DAA) is a potent PPARalpha/gamma dual activator. Furthermore, we examined the anti-inflammatory effects of DAA in stimulated macrophages and in the coculture of macrophages and adipocytes. DAA significantly suppressed the production of proinflammatory mediators such as MCP-1, TNF-alpha, and NO in stimulated RAW 264 macrophages and in the coculture of RAW 264 macrophages and 3T3-L1 adipocytes. These results suggest that DAA is a valuable medicinal and food component for improving inflammatory changes associated with obesity-related diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18267111     DOI: 10.1016/j.bbrc.2008.02.002

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 2.  Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes.

Authors:  Jun Panee
Journal:  Cytokine       Date:  2012-07-04       Impact factor: 3.861

3.  Dehydroabietic acid reverses TNF-α-induced the activation of FOXO1 and suppression of TGF-β1/Smad signaling in human adult dermal fibroblasts.

Authors:  Xiao-Wei Wang; Yong Yu; Lei Gu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Various Terpenoids Derived from Herbal and Dietary Plants Function as PPAR Modulators and Regulate Carbohydrate and Lipid Metabolism.

Authors:  Tsuyoshi Goto; Nobuyuki Takahashi; Shizuka Hirai; Teruo Kawada
Journal:  PPAR Res       Date:  2010-06-03       Impact factor: 4.964

Review 5.  Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies.

Authors:  Shizuka Hirai; Nobuyuki Takahashi; Tsuyoshi Goto; Shan Lin; Taku Uemura; Rina Yu; Teruo Kawada
Journal:  Mediators Inflamm       Date:  2010-05-25       Impact factor: 4.711

6.  Wide-range screening of anti-inflammatory compounds in tomato using LC-MS and elucidating the mechanism of their functions.

Authors:  Shinsuke Mohri; Haruya Takahashi; Maiko Sakai; Shingo Takahashi; Naoko Waki; Koichi Aizawa; Hiroyuki Suganuma; Takeshi Ara; Yasuki Matsumura; Daisuke Shibata; Tsuyoshi Goto; Teruo Kawada
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

Review 7.  The potential of natural products for targeting PPARα.

Authors:  Daniela Rigano; Carmina Sirignano; Orazio Taglialatela-Scafati
Journal:  Acta Pharm Sin B       Date:  2017-06-16       Impact factor: 11.413

8.  Biological activities and cytotoxicity of diterpenes from Copaifera spp. Oleoresins.

Authors:  Fabiano de S Vargas; Patrícia D O de Almeida; Elenn Suzany P Aranha; Ana Paula de A Boleti; Peter Newton; Marne C de Vasconcellos; Valdir F Veiga Junior; Emerson S Lima
Journal:  Molecules       Date:  2015-04-09       Impact factor: 4.411

9.  Synthesis and antibacterial evaluation of New N-acylhydrazone derivatives from dehydroabietic acid.

Authors:  Wen Gu; Rongrong Wu; Shilong Qi; Chenhai Gu; Fanjunnan Si; Zhuhui Chen
Journal:  Molecules       Date:  2012-04-20       Impact factor: 4.411

10.  Synthesis and Biological Evaluation of Novel Dehydroabietic Acid-Oxazolidinone Hybrids for Antitumor Properties.

Authors:  Xiu Wang; Fu-Hua Pang; Lin Huang; Xin-Ping Yang; Xian-Li Ma; Cai-Na Jiang; Fang-Yao Li; Fu-Hou Lei
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.